News

Marie Claire on MSN4h
An Aggressive Topical Treatment Brought Five Decades of Sun Damage to My Skin's Surface
But because of that, my sun exposure throughout my life has been horrible. I started with tanning beds when I was a child ...
Medscape18h
FDA Expands Approval of Roflumilast Foam for Treating Scalp, Body Psoriasis
The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.
The American Journal of Managed Care20h
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis
Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...